News & Events
Gretchen Bowker to hold webinar via ComplianceOnline on March 19th
Pearl Pathways’ own COO and Co-Founder, Gretchen Bowker will be holding a webinar on FDA regulatory requirements for the manufacturing and commercialization of dietary supplements via ComplianceOnline. A few of the topics include a review of FDA regulations in the...
The Institute of Medicine shows support for clinical trial transparency
The US Institute of Medicine (IoM) has recently released a report supporting the movement for full transparency in clinical trial information saying, “releasing information is in the public interest and maximizes the contributions made by clinical trial participants...
US congressmen head initiative to improve clinical trial process
Fred Upton, chairman of the House Energy and Commerce Committee, and Rep. Diana DeGette have recently launched the 21st Century Cures initiative, a bill intended to improve clinical trials and expedite the drug and device approval process. Upton and Degette plan to...
Pearl Pathways will be attending DA4S – West Coast
Diversity Alliance for Science (DA4S) is a non-profit organization focused on supporting, developing, and connecting with a diverse group of suppliers in the Life Science, Pharmaceutical, Bio-Tech, and Healthcare industries. Our President and CEO is attending the DA4S...
Pearl IRB announces AAHRPP accreditation
Pearl IRB is proud to announce its recent accreditation with the Association for the Accreditation of Human Research Protection Programs (AAHRPP). Pearl IRB earned this distinction by demonstrating two primary techniques including extensive safeguards in all levels of...